Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Rx Education Campaign To Have Three Phases, Will Stress Urgency

Executive Summary

The Centers for Medicare & Medicaid Services three-step Medicare Part D benefit education campaign will focus on beneficiary awareness, decision-making and urgency, CMS Director of Medicare Outreach Julie Goon said

You may also be interested in...



Medicare Rx Risk-Sharing Deals Not Covered By Safe Harbors, Attorneys Say

Drug manufacturers and Medicare Part D drug plan sponsors may be misinterpreting the Medicare Modernization Act as they form risk-sharing arrangements, Sidley Austin Brown & Wood Partner William Sarraille told the Pharmaceutical Compliance Summit March 30 in Philadelphia

Medicare Rx Risk-Sharing Deals Not Covered By Safe Harbors, Attorneys Say

Drug manufacturers and Medicare Part D drug plan sponsors may be misinterpreting the Medicare Modernization Act as they form risk-sharing arrangements, Sidley Austin Brown & Wood Partner William Sarraille told the Pharmaceutical Compliance Summit March 30 in Philadelphia

CMS Extends Medicare Rx Auto-Enrollment To Low-Income Beneficiaries

The Centers for Medicare & Medicaid Services will auto-enroll beneficiaries qualified for low-income subsidies in the drug benefit

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045508

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel